RINPHARM is a Russian pharmaceutical company which provides a full range of services related to distribution and sales of pharmaceutical products in Russia. Our main activity is the wholesale trade of finished products for medical use, which includes import, logistics, marketing and sales. Over the past few years, RINPHARM has also been actively developing, manufacturing and marketing its’ own products to meet the needs of patients with rare (orphan) diseases, therapy for symptomatic and chronic pain syndromes, and for the treatment of some other neurological diseases. The history of our company began in 2008 as an exclusive distributor of several niche pharmaceutical products, including those for the treatment of orphan diseases. In 2012, the company was restructured and renamed into RINPHARM. Today, RINPHARM is an active participant of the Russian pharmaceutical distribution chain, providing a full range of marketing services and distributing a wide range of pharmaceutical products. All employees of our company are united by professionalism, connections and experience gained in leading Russian and foreign pharmaceutical companies. The competence and responsibility of our employees enable us to fully meet the highest requirements of our business partners and global quality standards. Today, one of the promising areas of the company's long-term development is the expansion and filling the product portfolio with our own products, fully produced in Russia or the EAEU countries. Our product portfolio consists of generics and original products, which are at various stages of pharmaceutical development, research and state registration.
RINPHARM owns several products that have proven to be quality, competitive and effective medicines with a steady consumer demand. Knowing firsthand the problems of Russian patients with orphan diseases, we strive to increase the effectiveness of their treatment. Our goal is to provide them with modern, effective and safe pharmaceuticals at affordable prices.
Our team of professionals, together with leading experts and partners in the development, research, state registration and manufacturing of medicines, implements tasks from the idea to the production of finished products, including the active pharmaceutical ingredient (API):
- Research and Development, starting from API
- State registration in compliance with the requirements of EAEC
- Production of Finished Dosage Forms (FDF) using leading Russian and foreign contract manufacturers which are fully compliant with EU GMP requirements
- Quality Assurance & Quality Control, product release for circulation in the Russian Federation in accordance with the legislation requirements
- Pharmacovigilance / Drug-safety (monitoring medicines effectiveness and safety) and interaction with end-users
The careful selection of our service providers, continuous quality control of our work in order to comply with GDP standards, and participation of each employee in monitoring all business processes within the company are key factors that ensure the quality of our work. It gives us confidence in the successful fulfillment of our commitments and allows RINPHARM to be a reliable, responsible, and punctual business partner.